PLC Systems to Host Third Quarter Conference Call on November 13, 2008

FRANKLIN, Mass., Nov. 5  /PRNewswire-FirstCall/ -- PLC Systems Inc. (AMEX:PLC) announced today that it expects to release to the news wire its financial results for the third quarter ended September 30, 2008 before the market opens on Thursday, November 13, 2008. The company plans to host a conference call to discuss those results at 11:00 a.m. ET on that same day.

The call may be joined via telephone by dialing [phone] or [phone] (for international participants) at least ten minutes prior to the start of the call. The conference ID code is: 37030504. A live webcast of the conference call will be available by visiting the PLC Systems website, http://www.plcmed.com/ five minutes before the call begins. The webcast will be archived on this site starting one hour after the call is completed. In addition, a telephonic replay of the call will be available beginning at 1:00 p.m. EDT on November 13, 2008, through midnight on November 20, 2008, and can be accessed by dialing [phone] or [phone] (for international participants), using conference ID code 60872943.

About PLC Systems Inc.

PLC Systems Inc. is a medical technology company specializing in innovative technologies for the cardiac and vascular markets.

PLC's newest product, RenalGuard(TM), is approved for sale in the EU as a general fluid balancing device. The RenalGuard System(TM) consists of a unique, proprietary, closed loop, software-controlled console and accompanying single-use sets that can be used by physicians and nurses to balance patient fluid levels during a variety of medical procedures. The RenalGuard System, with its matched fluid replacement capability, is intended to minimize the risk of over- or under-hydration during medical procedures where creating and maintaining high urine outputs is deemed beneficial to patients.

Headquartered in Franklin, Massachusetts, PLC pioneered the CO2 Heart Laser System, which cardiac surgeons use to perform CO2 transmyocardial revascularization (TMR) to alleviate symptoms of severe angina. CO2 TMR offers a treatment option for angina patients who suffer from severe coronary artery disease. The CO2 Heart Laser is the world's first TMR angina relief device cleared for commercial distribution by both the U.S. Food and Drug Administration and Japanese Ministry of Health, Labor and Welfare, and to obtain a CE Mark for European distribution. Additional company information can be found at http://www.plcmed.com/.

PLC Systems, PLC Medical Systems, PLC, CO2 Heart Laser, RenalGuard, RenalGuard System and RenalGuard Therapy are trademarks of PLC Systems Inc.

  Contact: Mary T. Conway
  Conway Communications
  617-244-9682
  

DATASOURCE: PLC Systems Inc.



CONTACT:  Mary T. Conway of Conway Communications for PLC Systems Inc.,

[phone], 



Web site:  http://www.plcmed.com/ 

Copyright